Published Feb 16, 2024

Reverse Aging & Reduce Inflammation with OneSkin’s Carolina Oliveira | 287 | Kelly LeVeque

Carolina Oliveira, CEO of OneSkin, unveils the cutting-edge role of peptides in reversing skin aging, discussing the development of the OS-O1 peptide which targets senescent cells to rejuvenate skin and reduce biological age, alongside an innovative eye cream with remarkable clinical outcomes.
Episode Highlights
Be Well by Kelly Leveque logo

Popular Clips

Episode Highlights

  • Future Innovations

    Carolina Oliveira, CEO of OneSkin, emphasizes the continuous evolution of skincare science. Her team is dedicated to developing new formulations and improving existing ones, focusing on peptides and other molecules to enhance product efficacy. Carolina shares her excitement about future innovations, hinting at upcoming developments that target various aging areas, though specifics remain under wraps 1.

    Yeah, no, I think one of the things that we are very excited at one skin is that the science continues to evolve. So we will continue to evolve.

    ---

    Kelly LeVeque discusses the potential of OneSkin's body care products to lower cytokines in the blood, showcasing the brand's commitment to holistic skincare advancements 2.

       

    Eye Cream Breakthrough

    OneSkin's innovative eye cream formulation is designed to combat accelerated aging around the eyes. Carolina highlights the product's enhanced peptide concentration and other active ingredients that address puffiness and dark circles. Clinical studies reveal impressive results, with participants experiencing effects akin to an eye-lifting surgery after twelve weeks of use 3.

    We treated these participants for twelve weeks and it seemed that they had done like an eye lifting surgery.

    ---

    Kelly shares her personal experience with the eye cream, noting significant improvements in skin hydration and plumpness, which she attributes to the product's efficacy 3.

Related Episodes